Browsing HLS Student Papers by Title
Now showing items 110-129 of 498
-
AN ECONOMIC ANALYSIS OF FOOD AND DRUG LAW: Selected Topics in FDA Enforcement
(1995)In this paper, I hope to introduce the world of Law & Economics to the world of FDA enforcement. By no means is this an effort to analyze every problem dealing with the subject of FDA enforcement. Similarly, the purpose ... -
An Edict from the Thought Police: Reconciling American and European Approaches to Geographical Designations
(1997)The United States is, relatively speaking, a young country, built by immigrants who tried to replicate the best of the world they left behind. The European Union is, strictly speaking, even younger than the U.S., but its ... -
Education or Promotion?: Industry-Sponsored Continuing Medical Education (CME) as a Center for the Core/Commercial Speech Debate
(2003)Because of its importance to determining drug usage, information has always been an important part of the regulation of prescription drugs. The Food and Drug Administration (FDA) and the pharmaceutical industry are in a ... -
THE EFFECT OF FDA'S POLICIES ON THE DECREASING EFFECTIVENESS OF ANTIBIOTICS
(1995)This paper will evaluate the effect that the Food and Drug Administration (FDA) has had on the drug resistance problem and will consider how the FDA could tailor its regulatory policies to better safeguard the effectiveness ... -
The Effect of Managed Care on the Pharmaceutical Industry
(1997)The pharmaceutical industry has transformed itself in response to the growth of managed care, which developed as a method to contain the costs of health care. Under the traditional fee-for-service system of practicing ... -
The Effects of False Claims Act Whistleblowers on the Pharmaceutical Industry
(2006)The whistleblower (or “qui tamâ€) provisions of the False Claims Act allow private citizens to bring suit on behalf of the government against individuals or corporations who have submitted ... -
Eliminating Earmarks: Why the Congressional Line Item Vote Can Succeed Where the Presidential Line Item Veto Failed
(2009-12-05)Congressional earmarking is an issue of growing concern in the United States. Although it currently accounts for a small percentage of federal expenditures, recent trends indicate that such pork-barrel spending will soon ... -
The Elusive Silver Bullet: FDA Failures, Rejected New Drug Applications, and the Search for an Obesity Cure
(2011)Over the past forty-five years, America has fallen victim to an obesity epidemic, affecting more than thirty percent of American adults. If the incidence of obesity continues at current rates, an estimated forty-percent ... -
The Emerging Field of Race-Based Genetic Research: Can We Trust It?
(2006)In June of 2005, the Food and Drug Administration approved a heart disease drug named BiDil exclusively for African Americans, provoking a fiery debate among medical researchers, sociologists, and legal scholars. On the ... -
Empowering Women: A Feminist Argument for Over-the-Counter Sale of Oral Contraceptives
(2005)The oral contraceptive pill, having been on the market for 45 years, should be sold over-the-counter. There is no longer any valid reason for FDA to maintain the prescription status of the drug. First, numerous studies ... -
English is not Enough: The Language of Food and Drug Labels
(2002)Food and drug labels must respond to the needs of the increasing linguistic minority population in the United States. Currently, the FDA only requires that food and drug labels be in English. Due to the growing segment of ... -
Ensuring a Consistent Supply of Anthrax Vaccine
(2002)During the recent anthrax attacks, the country's supply of anthrax vaccine was dangerously low. The reasons for this were (1) the failure of the FDA, the Defense Department, and its contractor, BioPort Corporation, to plan ... -
Ephedra and the FDA
(2001)The adverse events experienced after ingesting ephedra and other dietary supplements have demonstrated the need for FDA intervention. The FDA has an important role to play in safeguarding the health and safety of the ... -
Equitable Division of International Joint Costs in Pharmaceutical Research and Development
(2004)Significant increases in pharmaceutical spending over the past two decades have lead to public outrage over the cost of prescription drugs. Pharmaceutical research and development is an expensive process – ... -
Establishing a No-Fault Compensation System to Replace Failure-to-Warn Product Liability Claims Against Prescription Drug Manufacturers
(2014-03-18)In 1986, Congress passed the National Childhood Vaccine Injury Act, which established a no-fault compensation system to provide money to people who are injured by vaccines. The major impetus behind this Act was the soaring ... -
Estimating Inequality with Tax Data: The Problem of Pass-Through Income
(2015)In recent decades, a growing share of U.S. business income has been taxed on a pass-through basis. When taxed on a pass-through basis, business income is attributed to a firm’s owners and taxed to them as individual income, ... -
The Ethical and Regulatory Problems in the Stem Cell Scandal
(2006)The recent stem cell scandal of fabrication of two papers published in Science by Dr. Hwang Woo Suk shocked the world and devastated the South Korean society. Investigations conducted by the South Korean government have ... -
An Evaluation of the Legal Responses to America's Obesity Epidemic
(2004)This paper will examine the recent legal action surrounding one of America's major public health problems; obesity. The discussion begins with a quick presentation of information regarding our nation's obesity epidemic. ... -
Evergreening: A Common Practice to Protect New Drugs
(2011)Exclusivity periods serve as an incentive for pharmaceutical companies to engage in the costly and risky activities underlying drug discovery and development. Patents offer one form of exclusivity. Other exclusivities are ... -
The Evolution and Future of the Medicare Chemotherapy Concession
(2004)Cancer is a life threatening disease that affects thousands of Americans each year. Chemotherapy is one of the most effective treatments for the disease, but its prohibitive cost makes it all but unavailable to those without ...